121 related articles for article (PubMed ID: 16078573)
1. [Study on the relationship between LOH and MI of FHIT gene and the development of cervical carcinoma].
Liu H; Peng ZL; Wang H; Liu SL; Zhang CS; Tang QP; He B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):506-9. PubMed ID: 16078573
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between the reduction of FHIT expression and the development of cervical carcinoma].
Liu H; Peng ZL; Yang KX; Liu SL; Wang H; Zhang CS; Fan YJ; Zheng A
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):846-8. PubMed ID: 15573771
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features.
Butler D; Collins C; Mabruk M; Barry Walsh C; Leader MB; Kay EW
J Pathol; 2000 Dec; 192(4):502-10. PubMed ID: 11113868
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and loss of heterozygosity of fragile histidine triad gene in lung hyperplastic lesions.
Zhang JX; Shen H
Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):313-7. PubMed ID: 12697461
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
Xiao YP; Wu DY; Xu L; Xin Y
World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
[TBL] [Abstract][Full Text] [Related]
6. FHIT alterations in cancerous and non-cancerous cervical epithelium.
Yoshino K; Enomoto T; Nakamura T; Sun H; Ozaki K; Nakashima R; Wada H; Saitoh J; Watanabe Y; Noda K; Murata Y
Int J Cancer; 2000 Jan; 85(1):6-13. PubMed ID: 10585575
[TBL] [Abstract][Full Text] [Related]
7. [Study on the relationship between microsatellite alterations of RASSF1A gene and the development of cervical carcinoma].
Zhao FX; Yan J; Liu RH; Wang XY; Liu LH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):345-7. PubMed ID: 19469170
[TBL] [Abstract][Full Text] [Related]
8. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
[TBL] [Abstract][Full Text] [Related]
9. Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis.
Huang LW; Chao SL; Chen TJ
Gynecol Oncol; 2003 Aug; 90(2):331-7. PubMed ID: 12893195
[TBL] [Abstract][Full Text] [Related]
10. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
Verri C; Roz L; Conte D; Liloglou T; Livio A; Vesin A; Fabbri A; Andriani F; Brambilla C; Tavecchio L; Calarco G; Calabrò E; Mancini A; Tosi D; Bossi P; Field JK; Brambilla E; Sozzi G;
Am J Respir Crit Care Med; 2009 Mar; 179(5):396-401. PubMed ID: 19096006
[TBL] [Abstract][Full Text] [Related]
11. Cervical intraepithelial neoplasia: prognosis by combined LOH analysis of multiple loci.
ELhamidi A; Hamoudi RA; Kocjan G; Du MQ
Gynecol Oncol; 2004 Sep; 94(3):671-9. PubMed ID: 15350357
[TBL] [Abstract][Full Text] [Related]
12. FHIT gene in gastric cancer: association with tumour progression and prognosis.
Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.
Herzog CR; Crist KA; Sabourin CL; Kelloff GJ; Boone CW; Stoner GD; You M
Mol Carcinog; 2001 Mar; 30(3):159-68. PubMed ID: 11301476
[TBL] [Abstract][Full Text] [Related]
14. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
15. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
16. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
[TBL] [Abstract][Full Text] [Related]
17. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
[TBL] [Abstract][Full Text] [Related]
18. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
[TBL] [Abstract][Full Text] [Related]
19. FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women.
Yang F; Cui Z; Liao Y; Tian R; Fan W; Jin Z; Hu Z; Yao S
Cancer Biomark; 2020; 27(3):303-312. PubMed ID: 31771040
[TBL] [Abstract][Full Text] [Related]
20. [Loss of heterozygosity at chromosome 6 as a marker of early genetic alterations in cervical intraepithelial neoplasias and microinvasive carcinomas].
Mazurenko NN; Bliev AIu; Bidzhieva BA; Peskov DIu; Snigur NV; Savinova EB; Kiselev FL
Mol Biol (Mosk); 2006; 40(3):436-47. PubMed ID: 16813163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
